Merck Kgaa
(MRK.D.DX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 3,691,000 | 3,848,000 | 3,727,000 | 3,891,000 | 3,861,000 |
| Cost of Goods | 1,320,000 | 1,395,000 | 1,299,000 | 1,331,000 | 1,296,000 |
| Gross Profit | 2,371,000 | 2,453,000 | 2,428,000 | 2,560,000 | 2,565,000 |
| Operating Expenses | 1,849,000 | 2,355,000 | 1,528,000 | 1,932,000 | 1,810,000 |
| Operating Income | 522,000 | 98,000 | 900,000 | 628,000 | 755,000 |
| Other Income | -66,000 | 50,000 | -64,000 | -71,000 | -71,000 |
| Pre-tax Income | 456,000 | 148,000 | 836,000 | 557,000 | 684,000 |
| Income Tax | 114,000 | -868,000 | 187,000 | 134,000 | 161,000 |
| Net Income Continuous | 342,000 | 1,015,000 | 649,000 | 423,000 | 523,000 |
| Minority Interests | -1,000 | -3,000 | -4,000 | -2,000 | -2,000 |
| Net Income | $341,000 | $1,013,000 | $645,000 | $421,000 | $521,000 |
| EPS Basic Total Ops | 0.78 | 2.33 | 1.48 | 0.97 | 1.20 |
| EPS Basic Continuous Ops | 0.78 | 2.33 | 1.48 | 0.97 | 1.20 |
| EPS Diluted Total Ops | 0.78 | 2.33 | 1.48 | 0.97 | 1.20 |
| EPS Diluted Continuous Ops | 0.78 | 2.33 | 1.48 | 0.97 | 1.20 |
| EBITDA(a) | $950,000 | $800,000 | $1,319,000 | $1,008,000 | $1,203,000 |